Rentschler Biopharma and Vetter unveil Xpert Alliance, a joint visualization of their successful strategic collaboration

29-Mar-2022

The visualisation is designed to “bring to life” this ongoing alliance and celebrate its successful operation, delivering effective solutions to address clients’ changing and expanding needs in the area of complex biopharmaceuticals

Rentschler Biopharma and Vetter, two globally operating Contract Development and Manufacturing Organisations (CDMOs), announced today that the companies are unveiling Xpert Alliance, a joint visualisation of their strategic collaboration. The visualisation is designed to “bring to life” this ongoing alliance and celebrate its successful operation, delivering effective solutions to address clients’ changing and expanding needs in the area of complex biopharmaceuticals.

In mid-2020, Vetter and Rentschler Biopharma entered this strategic alliance intended to create long-term value that enables clients to bring their complex products to patients more easily and faster, through the coordination of their respective manufacturing services. By offering complementary skills and experience along the biopharmaceutical value chain, together, the two CDMOs have mutually enhanced their services, evidenced by the strong progress in their ongoing initial joint client projects. Since that time, the two independent companies have worked closely together to advance this important alliance.

Today’s announcement marks an important step in heightening the visibility of the collaborative services to clients, as the strategic alliance matures.

“It is exciting to see how our alliance has been steadily evolving and taking shape,” stated Dr. Frank Mathias, CEO of Rentschler Biopharma. “We and Vetter have ambitious goals for our collaboration and believe that our clients can greatly benefit from the complementary services and seamless interactions we offer, with the ultimate aim of bringing new, life-changing treatment options to patients.”

Vetter Managing Director Peter Soelkner agreed: “With joint projects ongoing, the day-to-day workings of our strategic alliance are running smoothly, as we work together to create best-in-class solutions for our clients from early development stage through to the market. We are pleased with the progress we have made so far and look forward to demonstrating the added value we are generating through our collaboration.”

Xpert Alliance, the name of the joint visualisation introduced today, clearly indicates what this strategic collaboration of two leading CDMOs can offer, and the tagline – from substance to product to patient – outlines the breadth of the offering. The coming together of Rentschler Biopharma and Vetter is visually represented by the two shades of blue in the X – each of the company’s corporate colours. At the same time, the companies retain their individuality, as shown by the two names as part of the joint logo. Xpert Alliance embodies the true essence of this important collaboration, and the visualisation marks another milestone in this strong and growing partnership.

Sign up for your free email newsletter

Featured Companies